3Tun P A, Nathan D M, Permulter L C. Cognitive and affective disorders in elderly diabetics[J]. Clin Geriatr Med, 1990, 6(4):731.
4Liao D, Cooper L, , et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control: the ARIC study[J]. Stroke, 1996, 27(12): 2262.
5U' ren R C, Riddle M C, Lezak M D, et al. The mental efficiency of the elderly person with type Ⅱ diabetes mellitus[J].Am Geriatr Soc, 1990, 38(5): 505.
6Desmond David W, Tatemichi, Thomask, et al. Risk factors for cerebrovascular disease as correlates of cognitive function in a Stroke-FreeCohort[J]. Arch Neurol,1993, 50(2):162.
7EliasPK, EliasMF, D'AgostinoRB, etal. NIDDM and blood pressure as risk factors for poor cognitive performance[ J].Diabetes Care, 1997,20(9): 1388.
8Singh R, Barden A, Mori T, et al. Advanced glycation endproducts: a review[J]. Diabetologia, 2001, 44(2): 129.
9Weigin Zhao, Hui Chen, Hui Xu, et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats[J]. J Biol Chem, 1999,274(49): 34893.
8Balaji V,Balaji MS,Alexander C,et al.Premixed insulin aspart 30(Biasp30)vs.premixed human insulin30(BHI30)in gesta-tional diabetes mellitus--a pilot study[J].J Assoc Physicians Indi-a,2010,58:99-101.
9Brock Jacobsen I,Vind BF,Korsholm L,et al.Counter-regulato-ry hormone responses to spontaneous hypoglycaemia during treat-ment with insulin Aspart or human soluble insulin:a double-blinded randomized cross-over study[J].Acta Physiol(Oxf).2011,202(3):337-47.
